Bicarbonate Variation Monitoring With Indirect Calorimetry
NCT: NCT07782658 · NOT_YET_RECRUITING
Brief Summary
Patients admitted to the intensive care unit frequently exhibit abnormal blood bicarbonate levels. These abnormalities are associated with patient outcomes and often prompt clinicians to modify management, either diagnostically or therapeutically (e.g., initiation or adjustment of mechanical ventilation, initiation or modification of extracorporeal renal replacement therapy, administration of specific diuretics, or sodium bicarbonate infusion). Currently, the only way to determine blood bicarbonate concentration is through repeated blood sampling for laboratory analysis. However, this method is both discontinuous and invasive. We have generated an in silico hypothesis suggesting that the mismatch between cellular CO₂ production/elimination and pulmonary CO₂ elimination reflects changes in blood bicarbonate levels. We propose to test this hypothesis in a cohort of intensive care unit patients. If confirmed, indirect calorimetry could be positioned as a continuous, non-invasive monitoring tool for blood bicarbonate.
Frequently Asked Questions
What is Bicarbonate Variation Monitoring With Indirect Calorimetry?
Bicarbonate Variation Monitoring With Indirect Calorimetry is a clinical trial registered under NCT07782658. Current status: NOT_YET_RECRUITING.
What is the status of NCT07782658?
The current status of NCT07782658 (Bicarbonate Variation Monitoring With Indirect Calorimetry) is: NOT_YET_RECRUITING.
When did Bicarbonate Variation Monitoring With Indirect Calorimetry start?
Bicarbonate Variation Monitoring With Indirect Calorimetry started on 2026-11-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.